Thrombosis Service, HHS-General Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schulman, Sam -
TILE, NCT04794569: Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome

Terminated
4
9
Canada
tinzaparin, Rivaroxaban
Sunnybrook Health Sciences Centre, LEO Pharma, Sunnybrook Research Institute
Deep Vein Thrombosis, Post Thrombotic Syndrome
01/24
01/24
ENRICH-AF, NCT03950076 / 2019-002075-33: EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation

Active, not recruiting
4
948
Europe, Canada, US, RoW
Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy
Population Health Research Institute
Intracranial Hemorrhages, Atrial Fibrillation
04/26
10/26
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Recruiting
4
2760
Europe, Canada, RoW
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism
12/24
12/24
MUFFIN-PTS, NCT03833024: The Trial

Active, not recruiting
3
88
Canada
Micronized Purified Flavonoid Fraction, Venixxa group, Placebo, Placebo group
Sir Mortimer B. Davis - Jewish General Hospital
Post-Thrombotic Syndrome
03/24
05/24
PEITHO-3, NCT04430569 / 2018-000816-96: Pulmonary Embolism International THrOmbolysis Study-3

Recruiting
3
650
Europe, Canada, RoW
Alteplase, Placebo
Assistance Publique - Hôpitaux de Paris, Johannes Gutenberg University Mainz, Life Sciences Research Partners (D Collen Research Foundation), Canadian Institutes of Health Research (CIHR), Instituto de Salud Carlos III, International Network of VENous Thromboembolism Clinical Research Networks, Boehringer Ingelheim
Pulmonary Embolism
09/25
08/27
SAVER, NCT04319627 / 2021-001559-15: Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting
3
2700
Europe, Canada
Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo
Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
01/26
01/27
NCT05646394: Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Recruiting
N/A
150
Canada, RoW
Dual antiplatelet therapy, Aspirin, Plavix, Brilinta, Effient, Combined antithrombotic therapy, Vitamin K antagonist plus aspirin, Vitamin K antagonist plus antiaggregant, Vitamin K antagonist plus antiplatelet agent, Vitamin K antagonist standard intensity, VKA, Vitamin K antagonist high intensity
McMaster University, International Society on Thrombosis and Haemostasis
Antiphospholipid Syndrome, Arterial Thrombosis
07/27
12/27
Zondag, Michelle
LEADER-PAD, NCT04774159: Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Recruiting
3
6150
Canada
Colchicine 0.5 MG Oral Tablet, Colchicine, Colchicine-Placebo, Colchicine-Placebo tablet
Population Health Research Institute
Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation
04/29
04/29

Download Options